What is Zepp Health Corporation's earnings per share (EPS)?

Zepp Health Corporation (ZEPP) reported diluted earnings per share of $-0.16 for fiscal year 2025. This represents a 44.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Zepp Health Corporation Financials

ZEPP

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Zepp Health Corporation (ZEPP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ZEPP FY2024 2026-04-24

Zepp Health is becoming a smaller, higher-gross-margin business, but lost scale is overwhelming its fixed cost base.

Between FY2022 and FY2024, gross margin doubled from 19.4% to 38.5%, even though revenue kept contracting. R&D intensity climbed to about 25.3% of sales in FY2024, so the company appears to be retaining a heavier innovation cost base while shrinking toward higher-margin revenue, which explains why operating losses deepened instead of narrowing.

The balance sheet is not dominated by debt: total liabilities of $275.9M are only slightly above equity of $251.6M. But liquidity is tightening; cash fell to $91.1M and the current ratio is down to 1.3x, leaving less room to absorb another year of cash burn.

FY2023's positive free cash flow looked less like a durable earnings turn and more like a shrinkage benefit, because it arrived during another year of losses and collapsing sales. FY2024 reversed that support: operating cash flow slipped to -$24.4M and free cash flow to -$25.8M, showing that accounting losses are again being matched by real cash outflow.

Financial Health Signals

Financial Profile 21/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Zepp Health Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Zepp Health Corporation has an operating margin of -11.3%, meaning the company retains $-11 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -25.9% the prior year.

Growth

Zepp Health Corporation's revenue surged 41.8% year-over-year to $258.9M, reflecting rapid business expansion. This strong growth earns a score of 9/100.

Leverage

Zepp Health Corporation carries a low D/E ratio of 0.28, meaning only $0.28 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Zepp Health Corporation's current ratio of 1.02 is below the typical benchmark, resulting in a score of 15/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While Zepp Health Corporation generated -$25.7M in operating cash flow, capex of $516K consumed most of it, leaving -$26.2M in free cash flow. This results in a low score of 8/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Zepp Health Corporation generates a -18.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -30.1% the prior year.

Piotroski F-Score Neutral

4/9

Zepp Health Corporation passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.64x

For every $1 of reported earnings, Zepp Health Corporation generates $0.64 in operating cash flow (-$25.7M OCF vs -$40.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-5.1x

Zepp Health Corporation earns $-5.1 in operating income for every $1 of interest expense (-$29.2M vs $5.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$258.9M

YoY+41.8%

5Y CAGR-23.5%

Zepp Health Corporation generated $258.9M in revenue in fiscal year 2025. This represents an increase of 41.8% from the prior year.

EBITDA

-$24.7M

YoY+41.5%

Zepp Health Corporation's EBITDA was -$24.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 41.5% from the prior year.

Net Income

-$40.1M

YoY+47.1%

Zepp Health Corporation reported -$40.1M in net income in fiscal year 2025. This represents an increase of 47.1% from the prior year.

EPS (Diluted)

$-0.16

YoY+44.8%

Zepp Health Corporation earned $-0.16 per diluted share (EPS) in fiscal year 2025. This represents an increase of 44.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$26.2M

YoY-1.6%

Zepp Health Corporation generated -$26.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 1.6% from the prior year.

Cash & Debt

$57.0M

YoY-37.4%

5Y CAGR-30.4%

Zepp Health Corporation held $57.0M in cash against $59.5M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

136M

Zepp Health Corporation had 136M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

38.3%

YoY-0.2pp

5Y CAGR+17.6pp

Zepp Health Corporation's gross margin was 38.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.2 percentage points from the prior year.

Operating Margin

-11.3%

YoY+14.6pp

5Y CAGR-14.0pp

Zepp Health Corporation's operating margin was -11.3% in fiscal year 2025, reflecting core business profitability. This is up 14.6 percentage points from the prior year.

Net Margin

-15.5%

YoY+26.0pp

5Y CAGR-19.0pp

Zepp Health Corporation's net profit margin was -15.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 26.0 percentage points from the prior year.

Return on Equity

-18.7%

YoY+11.4pp

5Y CAGR-27.1pp

Zepp Health Corporation's ROE was -18.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 11.4 percentage points from the prior year.

Capital Allocation

R&D Spending

$45.3M

YoY-1.8%

5Y CAGR-11.3%

Zepp Health Corporation invested $45.3M in research and development in fiscal year 2025. This represents a decrease of 1.8% from the prior year.

Share Buybacks

$1.2M

YoY-45.7%

Zepp Health Corporation spent $1.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 45.7% from the prior year.

Capital Expenditures

$516K

YoY-63.2%

5Y CAGR-47.4%

Zepp Health Corporation invested $516K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 63.2% from the prior year.

ZEPP Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$258.9M+41.8%	$182.6M-48.3%	$352.9M-42.5%	$613.6M-37.4%	$980.8M-0.5%	$986.0M
Cost of Revenue	$159.7M+42.1%	$112.4M-56.9%	$260.5M-47.4%	$494.8M-36.2%	$775.9M-0.7%	$781.7M
Gross Profit	$99.2M+41.2%	$70.2M-24.0%	$92.4M-22.3%	$118.9M-42.0%	$204.9M+0.3%	$204.2M
R&D Expenses	$45.3M-1.8%	$46.2M-10.4%	$51.5M-33.4%	$77.3M-4.4%	$80.8M-2.0%	$82.5M
SG&A Expenses	$29.3M+17.8%	$24.9M-7.2%	$26.8M-23.7%	$35.1M-13.4%	$40.5M+1.0%	$40.1M
Operating Income	-$29.2M+38.1%	-$47.3M-55.2%	-$30.4M+50.8%	-$61.9M-519.6%	$14.7M-44.8%	$26.7M
Interest Expense	$5.7M+2.6%	$5.6M-17.4%	$6.7M-18.7%	$8.3M+17.3%	$7.0M-0.4%	$7.1M
Income Tax	$2.5M-81.5%	$13.7M+663.5%	-$2.4M+75.4%	-$9.9M-685.1%	$1.7M-64.7%	$4.8M
Net Income	-$40.1M+47.1%	-$75.7M-144.1%	-$31.0M+28.3%	-$43.2M-300.0%	$21.6M-38.3%	$35.1M
EPS (Diluted)	$-0.16+44.8%	$-0.29-123.1%	$-0.13+27.8%	$-0.18-325.0%	$0.08-38.5%	$0.13

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19	Q4'18
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ZEPP Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$564.8M+6.9%	$528.6M-16.8%	$635.5M-16.8%	$763.7M-20.0%	$955.0M+5.5%	$904.8M
Current Assets	$293.5M+16.7%	$251.6M-20.6%	$316.7M-26.2%	$428.9M-30.5%	$616.9M-16.6%	$739.9M
Cash & Equivalents	$57.0M-37.4%	$91.1M-31.9%	$133.7M+4.0%	$128.6M-44.2%	$230.4M-33.9%	$348.4M
Inventory	$72.8M+28.1%	$56.8M-33.1%	$84.9M-42.7%	$148.2M-24.4%	$196.0M+5.1%	$186.6M
Accounts Receivable	$66.9M+6.3%	$63.0M+3.7%	$60.7M-38.6%	$98.9M+17.3%	$84.3M+84.5%	$45.7M
Goodwill	$9.6M0.0%	$9.6M0.0%	$9.6M0.0%	$9.6M0.0%	$9.6M0.0%	$9.6M
Total Liabilities	$350.3M+27.0%	$275.9M-2.4%	$282.8M-24.5%	$374.5M-24.3%	$494.6M+1.7%	$486.4M
Current Liabilities	$286.8M+46.8%	$195.4M+26.0%	$155.1M-35.9%	$241.9M-28.4%	$337.7M-21.0%	$427.5M
Long-Term Debt	$59.5M-21.0%	$75.2M-37.3%	$120.0M+21.0%	$99.2M-13.0%	$114.1M+1140.4%	$9.2M
Total Equity	$214.5M-14.7%	$251.6M-28.3%	$350.9M-9.4%	$387.5M-15.4%	$458.3M+9.5%	$418.4M
Retained Earnings	-$11.4M-140.0%	$28.6M-72.6%	$104.4M-23.7%	$136.7M-31.5%	$199.5M+14.8%	$173.7M

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19	Q4'18
Total Assets	$564.8M+6.9%	$528.6M-16.8%	$635.5M-16.8%	$763.7M-20.0%	$955.0M+5.5%	$904.8M+21.7%	$743.3M+56.8%	$473.9M
Current Assets	$293.5M+16.7%	$251.6M-20.6%	$316.7M-26.2%	$428.9M-30.5%	$616.9M-16.6%	$739.9M+17.3%	$630.9M+51.8%	$415.6M
Cash & Equivalents	$57.0M-37.4%	$91.1M-31.9%	$133.7M+4.0%	$128.6M-44.2%	$230.4M-33.9%	$348.4M+34.5%	$259.0M+23.5%	$209.7M
Inventory	$72.8M+28.1%	$56.8M-33.1%	$84.9M-42.7%	$148.2M-24.4%	$196.0M+5.1%	$186.6M+45.3%	$128.4M+82.1%	$70.5M
Accounts Receivable	$66.9M+6.3%	$63.0M+3.7%	$60.7M-38.6%	$98.9M+17.3%	$84.3M+84.5%	$45.7M+68.3%	$27.1M+216.7%	$8.6M
Goodwill	$9.6M0.0%	$9.6M0.0%	$9.6M0.0%	$9.6M0.0%	$9.6M0.0%	$9.6M+1024.5%	$852K-1.2%	$862K
Total Liabilities	$350.3M+27.0%	$275.9M-2.4%	$282.8M-24.5%	$374.5M-24.3%	$494.6M+1.7%	$486.4M+26.5%	$384.6M+82.5%	$210.7M
Current Liabilities	$286.8M+46.8%	$195.4M+26.0%	$155.1M-35.9%	$241.9M-28.4%	$337.7M-21.0%	$427.5M+19.9%	$356.5M+76.6%	$201.8M
Long-Term Debt	$59.5M-21.0%	$75.2M-37.3%	$120.0M+21.0%	$99.2M-13.0%	$114.1M+1140.4%	$9.2M	N/A	N/A
Total Equity	$214.5M-14.7%	$251.6M-28.3%	$350.9M-9.4%	$387.5M-15.4%	$458.3M+9.5%	$418.4M+16.5%	$359.2M+36.4%	$263.4M
Retained Earnings	-$11.4M-140.0%	$28.6M-72.6%	$104.4M-23.7%	$136.7M-31.5%	$199.5M+14.8%	$173.7M+32.8%	$130.8M+164.5%	$49.5M

ZEPP Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$25.7M-5.3%	-$24.4M-157.3%	$42.6M+136.4%	-$117.1M-221.1%	-$36.5M-251.3%	$24.1M
Capital Expenditures	$516K-63.2%	$1.4M-12.1%	$1.6M+32.0%	$1.2M-83.3%	$7.2M-43.6%	$12.8M
Free Cash Flow	-$26.2M-1.6%	-$25.8M-162.9%	$41.0M+134.7%	-$118.3M-170.8%	-$43.7M-486.7%	$11.3M
Investing Cash Flow	$1.5M+193.7%	-$1.6M-120.4%	$7.7M+223.9%	-$6.2M+96.3%	-$167.8M-429.2%	-$31.7M
Financing Cash Flow	$24.8M+5106.5%	$477K+101.1%	-$41.7M-198.4%	$42.4M-51.0%	$86.5M-0.1%	$86.5M
Dividends Paid	N/A	N/A	N/A	$6.3M	N/A	N/A
Share Buybacks	$1.2M-45.7%	$2.3M-9.5%	$2.5M-69.1%	$8.2M+277.9%	$2.2M	N/A

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19	Q4'18
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ZEPP Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	38.3%-0.2pp	38.5%+12.3pp	26.2%+6.8pp	19.4%-1.5pp	20.9%+0.2pp	20.7%
Operating Margin	-11.3%+14.6pp	-25.9%-17.3pp	-8.6%+1.4pp	-10.1%-11.6pp	1.5%-1.2pp	2.7%
Net Margin	-15.5%+26.0pp	-41.5%-32.7pp	-8.8%-1.7pp	-7.0%-9.3pp	2.2%-1.4pp	3.6%
Return on Equity	-18.7%+11.4pp	-30.1%-21.3pp	-8.8%+2.3pp	-11.2%-15.9pp	4.7%-3.7pp	8.4%
Return on Assets	-7.1%+7.2pp	-14.3%-9.4pp	-4.9%+0.8pp	-5.7%-7.9pp	2.3%-1.6pp	3.9%
Current Ratio	1.02-0.3	1.29-0.8	2.04+0.3	1.77-0.1	1.83+0.1	1.73
Debt-to-Equity	0.28-0.0	0.30-0.0	0.34+0.1	0.260.0	0.25+0.2	0.02
FCF Margin	-10.1%+4.0pp	-14.1%-25.8pp	11.6%+30.9pp	-19.3%-14.8pp	-4.5%-5.6pp	1.1%

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20	Q4'19	Q4'18
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.02-0.3	1.29-0.8	2.04+0.3	1.77-0.1	1.83+0.1	1.73-0.0	1.77-0.3	2.06
Debt-to-Equity	0.28-0.0	0.30-0.0	0.34+0.1	0.260.0	0.25+0.2	0.02-1.0	1.07+0.3	0.80
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

$171.0M

$1.8B

$427.4M

$5.0B

$2.2M

Frequently Asked Questions

What is Zepp Health Corporation's annual revenue?

Zepp Health Corporation (ZEPP) reported $258.9M in total revenue for fiscal year 2025. This represents a 41.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Zepp Health Corporation's revenue growing?

Zepp Health Corporation (ZEPP) revenue grew by 41.8% year-over-year, from $182.6M to $258.9M in fiscal year 2025.

Is Zepp Health Corporation profitable?

No, Zepp Health Corporation (ZEPP) reported a net income of -$40.1M in fiscal year 2025, with a net profit margin of -15.5%.

What is Zepp Health Corporation's EBITDA?

Zepp Health Corporation (ZEPP) had EBITDA of -$24.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Zepp Health Corporation have?

As of fiscal year 2025, Zepp Health Corporation (ZEPP) had $57.0M in cash and equivalents against $59.5M in long-term debt.

What is Zepp Health Corporation's gross margin?

Zepp Health Corporation (ZEPP) had a gross margin of 38.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Zepp Health Corporation's operating margin?

Zepp Health Corporation (ZEPP) had an operating margin of -11.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Zepp Health Corporation's net profit margin?

Zepp Health Corporation (ZEPP) had a net profit margin of -15.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Zepp Health Corporation's return on equity (ROE)?

Zepp Health Corporation (ZEPP) has a return on equity of -18.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Zepp Health Corporation's free cash flow?

Zepp Health Corporation (ZEPP) generated -$26.2M in free cash flow during fiscal year 2025. This represents a -1.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Zepp Health Corporation's operating cash flow?

Zepp Health Corporation (ZEPP) generated -$25.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Zepp Health Corporation's total assets?

Zepp Health Corporation (ZEPP) had $564.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Zepp Health Corporation's capital expenditures?

Zepp Health Corporation (ZEPP) invested $516K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Zepp Health Corporation spend on research and development?

Zepp Health Corporation (ZEPP) invested $45.3M in research and development during fiscal year 2025.

Does Zepp Health Corporation buy back shares?

Yes, Zepp Health Corporation (ZEPP) spent $1.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Zepp Health Corporation have outstanding?

Zepp Health Corporation (ZEPP) had 136M shares outstanding as of fiscal year 2025.

What is Zepp Health Corporation's current ratio?

Zepp Health Corporation (ZEPP) had a current ratio of 1.02 as of fiscal year 2025, which is considered adequate.

What is Zepp Health Corporation's debt-to-equity ratio?

Zepp Health Corporation (ZEPP) had a debt-to-equity ratio of 0.28 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Zepp Health Corporation's return on assets (ROA)?

Zepp Health Corporation (ZEPP) had a return on assets of -7.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Zepp Health Corporation's cash runway?

Based on fiscal year 2025 data, Zepp Health Corporation (ZEPP) had $57.0M in cash against an annual operating cash burn of $25.7M. This gives an estimated cash runway of approximately 27 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Zepp Health Corporation's Piotroski F-Score?

Zepp Health Corporation (ZEPP) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Zepp Health Corporation's earnings high quality?

Zepp Health Corporation (ZEPP) has an earnings quality ratio of 0.64x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Zepp Health Corporation cover its interest payments?

Zepp Health Corporation (ZEPP) has an interest coverage ratio of -5.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Zepp Health Corporation?

Zepp Health Corporation (ZEPP) scores 21 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.